...
首页> 外文期刊>Pediatric Hematology and Oncology >P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
【24h】

P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.

机译:I期和II期良好组织学Wilms肿瘤患者的P糖蛋白表达,肿瘤重量,年龄和复发。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fifteen percent of patients with Wilms' tumor (WT) experience relapse. It has been suggested that weight and age may affect the chances of relapse. Few studies have investigated the role, if any, between P-glycoprotein (P-gp) and relapse. The authors assessed the prognostic value of tumor weight and age at diagnosis and asked whether some other potential biological markers, specifically P-gp protein expression, had a prognostic value in favorable-histology WT. No association between age and relapse could be found. Patients with tumor weight >/=550 g were 6 times more likely to relapse, whereas P-gp expression was positive in 18/40 (45%) of the patients, of which 10/12 (83.3%) relapsed and 8/28 (28.6%) did not. Further studies are necessary to elucidate whether or not P-gp is related to relapse in patients with histologically favorable Wilms' tumor. If confirmed, the protein may be used in the future as a target for new drugs and treatments for this group of patients.
机译:15%的威尔姆斯肿瘤(WT)患者出现复发。已经提出,体重和年龄可能影响复发的机会。很少有研究调查P-糖蛋白(P-gp)与复发之间的作用。这组作者评估了肿瘤重量和年龄在诊断时的预后价值,并询问其他一些潜在的生物学标志物,特别是P-gp蛋白表达,是否在有利的组织学WT中具有预后价值。没有发现年龄和复发之间的关联。体重> / = 550 g的患者复发的可能性高6倍,而在18/40(45%)的患者中P-gp表达阳性,其中复发的10/12(83.3%)和8/28 (28.6%)没有。有必要进行进一步的研究来阐明组织学上有利的威尔姆斯肿瘤患者中P-gp是否与复发有关。如果得到证实,该蛋白将来可能会用作这类患者的新药和新疗法的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号